OPTOCIRCUI

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 39438.24 lacs for half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 10171.83 lacs for the half year ending on 30-SEP-2008.

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 21701.51 lacs for quarter ending on 30-SEP-2008 against Rs. 17736.72 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 5672.93 lacs for the quarter ending on 30-SEP-2008 against Rs. 4498.89 lacs for the quarter ending on 30-JUN-2008.

Opto Circuits (India) Limited has informed the Exchange that "The management of the company has evaluated the proposed acquisition of European company while the underlying the business is found to be very valuable and synergistically complementary, the demanded price is not justifiable from the economic value prospective. So the company is not considering the proposed European acquisition".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated October 01, 2008, titled "Opto's subsidiary EuroCor becomes first ever to Complete Aortic Valvuloplasty using Drug eluting balloon DIOR". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Opto_PR_01102008.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange that the Record Date for the purpose of issue of Bonus shares in the Ratio of 7:10 (Seven Bonus share for every Ten Equity shares held) as approved by the shareholders at their Annual General Meeting held on September 30, 2008 is fixed on November 04, 2008.

Opto Circuits (India) Limited has informed the Exchange regarding the outcome of Annual General Meeting of the Company held on September 30, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). <a href=/content/corporate/OptoCircuit_Outcome_30092008.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange that " Criticare System Inc, USA the company's wholly owned subsidiary has launched its two new series of patient monitors eQuality and Ncompass which were developed by company's in-house Research and Development team". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/OPTOCIR_UPDATE_25092008.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange that Eurocor GmbH the Company's wholly owned subsidiary has received registration for its Drug Eluting Balloon, Dior in India. The commercial release of Dior will commence after fulfilling the guidelines provided by Drug Control General of India (DCGI). The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/OPTO_UPDATES_24092008.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange that the Company has signed a non binding letter of Intent (LOI) for the proposed purchase of 100% of the capital stock of a privately held medical devices company in Europe manufacturing Medical Equipments. The acquisition is estimated over USD 100.00 million.

Opto Circuits (India) Limited has informed the Exchange that the Board of Directors at their meeting held on September 04, 2008 have deferred the decision of raising additional funds and will consider the same at the appropriate time.

Opto Circuits (India) Limited has informed the Exchange that the Register of Members and Share Transfer Books will be closed from September 26, 2008 to September 30, 2008 (both days inclusive) for the purpose of payment of dividend. The Annual General Meeting of the Members of the Company will be held on September 30, 2008.

Opto Circuits (India) Limited has informed the Exchange vide notes to Accounts in the audited financial results for the quarter and period ended March 31, 2008 (taken on record by the Board of Directors of the Company at its meeting held on May 27, 2008) regarding the utilisation of Public Issue Proceeds. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/optocir_27052008.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange that: The Company has recommended payment of 50% Dividend, subject to Share Holders approval in the Annual General Meeting. Further, the Company has recommended to issue Bonus Shares of 7 shares for every 10 shares held, subject to Share Holders approval in the Annual General Meeting.

Opto Circuits (India) Limited has informed the Exchange that "Mediaid Inc. wholly owned subsidiary of Opto Circuits (India) Limited received approval from the United States Food and Drug Administration (FDA) for key vital sign monitoring products. The Model 900 and Model 960 Vital Sign Monitors are the first Opto bed-side monitors to receive the crucial approval for marketing in the United States. Receiving approval for these high-end products opens up the U.S. hospital market. The Model 900 and 960 devices monitor Blood-oxygen, Blood-pressure and Temperature for a complete and quick assessmen

Opto Circuits (India) Limited has informed the Exchange that "The Company has successfully completed Acquisition of Criticare Systems, Inc. ("Criticare") (AMEX: CMD). And the said company i.e. Criticare Systems, Inc. will be wholly owned subsidiary company of Opto Circuits (India) Limited".

Opto Circuits (India) Limited has informed the Exchange that "We intend to announce the audited results of the Company for the financial year ended 31st March 2008 on or before 30th June 2008."

Opto Circuits (India) Limited has informed the Exchange that "The company has acquired a majority stake in Criticare Systems Inc. (AMEX:CMD), Upon the completion of the share transfer process, Criticare Systems will become a subsidiary of Opto Circuits. Having access to the expanded product line and leading edge technology offered by Criticare Systems will allow Opto Circuits to enter new markets and compete more effectively with leading manufacturer of Vital Sign Monitors, Anesthesia Monitors, Pulase Oximeters and Patient Monitors and accessories. In addition, the acquisition now adds anesthe

Opto Circuits (India) Limited has informed the Exchange that : "The Board of Directors of the Company at its meeting held on 2nd April, 2008 has approved the Investment upto Rs.18.00 Crores in the equity share capital of the Opto Infrastructure Limited. After this proposed investment, Opto Infrastructure Limited will be a Subsidiary Company of Opto Circuits (India) Limited."

Opto Circuits (India) Limited has informed the Exchange that: "The Company has signed definitive agreement for acquisition of US based company Criticare Systems Inc. (AMEX:CMD). The acquisition is estimated at USD 70.00 million. Criticare Systems Inc. is in the business of manufacturing vital sign monitors and anesthesia monitors and pulse Oximeters".

Opto Circuits (India) Limited has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the quarter ended December 31,2007 (taken on record by the Board of Directors of the Company at its meeting held on January 29, 2008) regarding the utilisation of Public Issue Proceeds. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Opto_IPO_30012008.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange that: "The Board of Directors of the Company at its meeting held on 29th January 2008 has approved the following, subject to satisfactory receipt of all statutory, regulatory, corporate and other approval including shareholders as may be required. 1) Issue upto 75,00,000 Convertible Share Warrants on Preferential basis to a) Promoters and Promoters Group, b) Directors of the Company, c) Directors of the Subsidiaries, d) Employees of the Company / Subsidiaries. The above convertible share warrants will be issued on preferential basis at a

Opto Circuits (India) Limited has informed the Exchange that "The company's status has been upgraded from Two Star Export Trading House Status to Three Star Export Trading House in accordance with the Provisions of EXIM Policy, from ministry of Commerce and Industry, Government of India."

Opto Circuits (India) Limited has informed the Exchange that "The company has received 510(k) approval from Food and Drug Administration USA (US FDA) for the new generation Pluse Oximeters model no M30 and M34, which would enable the company to market these Pluse Oximeters in United States of America (USA). The Model 34 can store data in memory for later review and documentation and also features a sleep mode for basic patient sleep screening. It also enables the data transfer through USB/IRDA".

Opto Circuits (India) Limited has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the quarter and half year ended September 30,2007 (taken on record by the Board of the directors of the Company at its meeting held on October 24, 2007) regarding the utilisation of Public Issue Proceeds. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Optocircu_util_25102007.zip target=NEW> For more details cli

Opto Circuits (India) Limited has informed the Exchange that: "The Record Date for the purpose of issue of Bonus shares in the Ratio of 1:2 (one Bonus share for every Two Equity shares held) as approved by the shareholders at their Annual General Meeting held on 25th September is fixed on 26th October 2007".

Opto Circuits (India) Limited has informed the Exchange that the following items were approved by the Shareholders of the Company at their Annual General Meeting held on September 25, 2007: 1) Payment of Dividend @ 50%. 2) Re-appointment of Mr. Vinod Ramnani as Director. 3) Re-appointment of Mrs. Usha Ramnani as Director. 4) Re-appointment of Mr. Jayesh Patel as Director. 5) Appointment of M/s Anand Shenoy and company Chartered Accountants as Statutory Auditors. 6) Appointment of Mr. William Walter O'Neill MD as Director of the company. 7) Increase in the Authorised capital from Rs.65.00 crore

Opto Circuits (India) Limited has informed the Exchange that: "The Company has entered into a Technology Transfer agreement with Elpro Srl - Italy to develop, manufacture, and market different variants of Electro Cardio Graphs Machines (ECG Machines). The Agreement covers 4 variants of ECG machines. The Agreement will give the Company ability to market the new variants of stand-alone ECG machines for domestic and international market."

Opto Circuits (India) Limited has informed the Exchange that the Register of Members and Share transfer Books of the Company will be closed from September 20, 2007 to September 25, 2007 for the purpose of payment of Dividend and Annual General meeting. The Board has recommend for payment of 50% dividend, subject to the approval of the shareholders at the Annual General Meeting. The Annual General meeting of the Members of the Company will be held on September 25, 2007.

Opto Circuits (India) Limited has informed the Exchange that: "The company has received formal approval from the Ministry of Commerce and Industry, Department of Commerce, Government of India for developing up SEZ at Nanjanagud near Mysore. The Company is likely to establish its new manufacturing facilities in the proposed SEZ. It will also focus on establishing manufacturing facilities for various Health Care related Hardware Electronic products"

Opto Circuits (India) Limited has informed the Exchange on July 14, 2007, that: "The Board of Directors of the company at their meeting held on this day inter-alia proceed with the allotment of the following securities on preferential basis. 1) 11,00,000 Convertible Share Warrants: i) Name of the Allottee - Mr. Vinod Ramnani; No of Warrants - 5,40,000. ii) Name of the Allottee - Mr. Jayesh C Patel; No of Warrants - 2,40,000. iii) Name of the Allottee - Mr. Bhaskar V; No of Warrants - 2,60,000. iv) Name of the Allottee - Mr. Manje Gowda; No of Warrants - 60,000. 2) 11,64,620 equity shares: i) N

Opto Circuits (India) Limited has informed the Exchange regarding Utilisation of Public Issue Proceeds. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/OptoCircuits_UtilisationofFunds.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange that the following items were approved by the Shareholders of the Company at their Extra ordinary General Meeting held on June 29, 2007. (1) Issue upto 12,00,000 Convertible Share Warrants on preferential basis to Promoters and Directors of the Subsidiary Companies. (2) Issue upto 12,00,000 Equity shares on preferential basis to FIIs and NRI.

Opto Circuits (India) Limited has informed the Exchange that the Board of Directors at its meeting held on June 29, 2007 have recommended 50% Dividend for the year 2006-2007 and also One Equity Bonus Shares for every Two fully paid Equity Shares, subject to the approval of the Shareholders in the General Meeting.

Opto Circuits (India) Limited has submitted to the Exchange a copy of the Corrigendum published in the Newspaper on June 27, 2007 regarding the Notice of the Extra ordinary General Meeting of the Company to be held on June 29, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/opto_corrEGM_270607.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has submitted to the Exchange a copy of the Notice of Extra ordinary General Meeting to be held on June 29, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/opto_egm_080607.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange that: "The Board of Directors of the Company at its meeting held on 24th May, 2007 has proposed the following subject to satisfactory receipt of all statutory, regulatory, corporate and other approval including shareholders at their Meeting, as may be acquired. 1) Issue up to 12,00,000 Convertible Warrants on preferential basis to a) Promoters and Promoters Group, b) Directors of the Company, c) Directors of the Subsidiaries, d) Employees of the Company. 2) Issue up to 12,00,000 Equity shares on preferential basis to Strategic Investors:

Opto Circuits (India) Limited has informed the Exchange that "An e mail "investorsservices@optoindia.com" is designated exclusively for the purpose of registering complaints by investors, which would also be displayed prominently as per the newly inserted clause for creating investors awareness."

Opto Circuits (India) Limited has informed the Exchange that "The Company has signed purchase agreements to acquire Medical Equipment Companies in India namely Devon Innovations Private limited and Ormed Medical Technology Limited. The Companies manufacture products like Catheters, Stone graspers, Stone Baskets, Dilator Sets etc, for different specialized applications mainly in the areas of Urology, Gastroenterology and Gynaecology. Devon Innovations manufacture Catheters and allied products for various medical segments and Ormed deals in Orthopaedic Prosthesis & Surgical Disposables. Both Com

Opto Circuits (India) Limited has informed the Exchange that "We intend to announce the audited results of the Company for the financial year ended 31st March, 2007 on or before 30th June, 2007. In view of this, we request to exempt us from announcing the Un-audited results."

Opto Circuits (India) Limited has informed the Exchange that "Mrs. Rose Chintamani, Company Secretary has resigned and Mr. R. Vijayendra is now appointed as Company Secretary with effect from 2nd February 2007. Mr. R. Vijayendra, is also designated as Compliance Officer".

Opto Circuits (India) Limited has informed the Exchange that Eurocor GmbH the Company's wholly owned subsidiary has launched its revolutionary product - DIOR, a pacllitaxel-eluting balloon dilation catheter used in PTCA (percutaneous transluminal coronary angioplasty) procedures. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Optocir_PR_20022007.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange that "Eurocor GmbH the Company's wholly owned subsidiary has received the CE Mark Approval for its "DIOR" a Paclitaxel Coated Ballon Catheter, used in treatment of Coronary in-stent restonosis. We are the first company in the world to have obtained CE for a Paclitaxel Coated Ballon Catheter. In March 2006 Eurocor Gmbh obtained CE certification for their Drug Eluting Stent TAXCOR, and in May 2006, for its Amadeus Supercross coronary dilation catheters used in vascular coronary perfusion and also for their new range of PTCA guide wires bran

Utilisation of Public Issue Proceeds :- Rs. in Lakhs. (1) Project cost :-Upgradation of Research & Development facility; Projected in Prospectus ( Rs. in lakhs ) :- 1938.00; Utilisation as at 31st December 2006( Rs. in lakhs ) :- 95.34; (2) Project cost :- Cost of Upgrading Infrastructure and for modernizing and acquisition of additional plant & machinery; Projected in Prospectus( Rs. in lakhs ) :- 1635.00; Utilisation as at 31st December 2006( Rs. in lakhs ) :- 848.28; (3) Project cost :- Investment in Mediaid Inc for establishing marketing offices; Projected in Prospectus( Rs. in lakhs ) :-

Opto Circuits (India) Limited has informed the Exchange that "The Company has been certified to ISO 13485:2003 from Underwriters Laboratories Inc. ISO 13485:2003 is an International Standard to provide a "harmonized" model for quality management system requirements that satisfy International Medical Device Regulations. Medical Device Manufacturers need to ensure that all medical devices are safe, fit for their intended purpose and that their design and manufacturing quality management systems meet Regulatory requirements. This standard is recognized worldwide as an international standard. It a

Opto Circuits (India) Limited has informed the Exchange that "The Company has signed a Letter of Intent to acquire a Medical Equipment Company in Europe. The Company designs and manufactures a wide range of balloon catheter assemblies and related products for coronary, renal and other applications. The acquisition is estimated at Rs. 72.00 crores and is subject to financial and legal due-diligence".

News Verification : The media had reports that Opto Circuits (India) Limited is close to announcing an overseas acquisition. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Opto Circuits (India) Limited has vide its letter inter-alia stated, "We would like to clarify that as a part of its business strategy, Opto Circuits (I) Ltd. is on a constant lookout for acquisitions and during this process, the company has app

Opto Circuits (India) Limited has informed the Exchange that the following items were approved by the Shareholders of the Company at their Annual General Meeting held on September 28, 2006. (a) Payment of dividend @ 40%. (b) Re-appointment of Mr. Jayesh C Patel as a Director. (c) Re-appointment of Mr. Thomas Dietiker as Director. (d) Re-appointment of Dr. Suleman Merchant as Director. (e) Appointment of M/s. Anand Shenoy and company Chartered Accountants as Statutory Auditors. (f) Appointment of Mr. V. Balasubramaniam as Director of the Company. (g) Appointment of Dr. Anvay Mulay as Director o

Opto Circuits (India) Limited has informed the Exchange that the Board of Directors at their meeting held on September 28, 2006 appointed Dr. William Walter O'Neil as additional Director of the company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).<a href=/content/corporate/Opto_280906.zip target=NEW> For more details click here.</a>

Opto Circuits (India) Limited has informed the Exchange that the record date for the purpose of issue of Bonus shares in the Ratio of 1:1 as approved by the shareholders at their Annual General Meeting held on September 28, 2006 is fixed on October 31, 2006.

Opto Circuits (India) Limited has informed the Exchange that the Register of Members and Share Transfer Books will be closed from September 22,2006 to September 28,2006 (both days inclusive) for the purpose of payment of dividend. The AGM of the Members of the Company will be held on September 28,2006.